RB1 and ovarian cancer: As shown in Figure 6A, approximately 20% of ovarian cancers (110 cases, 90% in stage III-IV) exhibited alterations (mRNA upregulation or amplification) in either leptin or OB-Rb levels (using an mRNA expression threshold Z-score±1 and a protein/phospho-protein expression threshold Z-score±2).